Skip to content

Effects of Soluble Phosphate in Humans

The Effect of Soluble Phosphate in Combination With Different Calcium Doses on Calcium and Phosphorus Metabolism in Healthy Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02095392
Enrollment
62
Registered
2014-03-24
Start date
2014-04-30
Completion date
2014-07-31
Last updated
2015-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Keywords

soluble phosphate, phosphorus metabolism, calcium metabolism, bone metabolism, human study

Brief summary

The study was conducted to investigate the effect of soluble phosphate in combination with different calcium doses on calcium and phosphorus metabolism and further physiological parameters in healthy subjects. The main aim of the study is to investigate the influence of a soluble phosphate supplementation on the fasting blood phosphate concentration and the dependency of an additional calcium intake.

Interventions

DIETARY_SUPPLEMENTP1000/Ca0

22 subjects consume for 8 weeks a beverage enriched with phosphate \[1g phosphorus/d\]

DIETARY_SUPPLEMENTP1000/Ca500

22 subjects consume for 8 weeks a beverage enriched with phosphate \[1 g phosphorus/d\] and calcium \[0,5 g calcium\]

DIETARY_SUPPLEMENTP1000/Ca1000

22 subjects consume for 8 weeks a beverage enriched with phosphate \[1 g phosphorus/d\] and calcium \[1 g calcium\]

DIETARY_SUPPLEMENTPlacebo

all participants consume two weeks before intervention the beverage without phosphate and calcium

Sponsors

University of Jena
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* age between 18-60 years * physical health

Exclusion criteria

* postmenopausal women * kidney diseases * diabetes mellitus * metabolic diseases * osteoporosis * intake of dietary supplements * pregnancy and lactation

Design outcomes

Primary

MeasureTime frame
Fasting phosphate concentration in blood8 weeks

Secondary

MeasureTime frameDescription
Calcium and phosphorus metabolism8 weeks* parameters of phosphate and calcium metabolism (1,25-OHD; 25-OHD;FGF23;PTH) * parameters of bone formation and resorption (osteocalcin, P1NP, CTX) * minerals in plasma, faeces and urine

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026